The annual EACR (European Association for Cancer Research) Congress brings together thousands of leading cancer researchers during four days to inspire innovation and build knowledge, connections and collaborations.
Founded in 1968 and with more than 10,000 members across 100+ countries worldwide, the EACR’s mission is the advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.
The 28th EACR Congress will be held in Seville, June 20-23, and will be dedicated to “Innovative Cancer Science: Translating Biology to Medicine” with a full program of conferences, scientific sessions and discussions about the tumour microbiome, molecular oncology, cancer detection and diagnosis, the biology of metastasis and many other topics related to cancer research.
It is also a great opportunity to network and explore the latest releases in the exhibition area, where ABYNTEK is participating with a booth (#28) presenting its ABYNTEK RESEARCH REAGENTS line of bioreagents for cancer research and the new range of CRISPR genome editing technology products.
Contact us to book a meeting with our technical team during the Congress. We will assist you to find the reagent that best suits your research.
ABYNTEK RESEARCH REAGENTS, A SOCIALLY RESPONSIBLE BRAND
In order to contribute to excellence in the supply of reagents for research, Abyntek has launched Abyntek Research Reagents, a battery of highest quality bioreagents for cancer research, including more than 6,000 antibodies, proteins and ELISA / CLIA kits for the study of hundreds of biomarkers of different types of cancer.
After 15 years of leadership in the supply of antibodies and other biological products, Abyntek makes top-level reagents for research in the oncological field available to the scientific community, with the technical support of its scientific team and under the highest quality standards.
But beyond the commitment to quality towards our clients and researchers, Abyntek pursues a firm social commitment and is locating part of the turnover of the Abyntek Research Reagents line to Breast Cancer research projects, either through donations to research groups or associations that work in this line, as well as through own R&D projects in this area.
CRISPR, ADVANCED GENOME ENGINEERING AT YOUR FINGERTIPS
The CRISPR/CAS9 system was discovered as a natural bacterial and archaeal defense against viruses. However, in recent years it has become the most widely used technology for genome editing. Researchers from all over the world are already using this method to perform specific changes in a wide variety of organisms, not only in basic but also in applied research.
Speed, efficiency, specificity and cost-effectiveness are some of its advantages, allowing modification of diverse cell types, including mammalian.
Abyntek provides an extensive catalogue and custom products validated by The Broad Institute of MIT and Harvard ensuring the best quality service. The experienced scientific team will guide you, boosting your research to another level.
Visit us at EACR Congress, Booth #28, and discover our extensive range of bioreagents for cancer research!
Don’t forget to request your discount code to apply in your next order. Just for meeting us at our booth!